DARE (Dare Bioscience) Tariff Resilience Score: 8/10 (As of Jul. 02, 2026)


DARE Dare Bioscience Inc DARE
23 GF Score
Price $2.09
! 4 Warning Signs
View Full Analysis

What is Dare Bioscience Tariff Resilience Score?

Dare Bioscience DARE -1.65% 23 Tariff Resilience Score is 8 as of Jul. 02, 2026. GuruFocus rates DARE with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 1,374 Biotechnology companies, Dare Bioscience ranks better than 98.69% on this metric.

Dare Bioscience has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Dare Bioscience has Dare Bioscience has low tariff exposure as a biotech firm with limited international supply chain dependencies. The industry is less affected by tariffs, and the company primarily operates within the U.S., minimizing its vulnerability to trade policy changes.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Dare Bioscience might have Highly Resilient.

Dare Bioscience  (NAS:DARE) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Dare Bioscience Tariff Resilience Score Related Terms

DARE vs ATNM, NNVC, LSTA: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Dare Bioscience's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dare Bioscience Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dare Bioscience's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Dare Bioscience's Tariff Resilience Score falls into.


DARE
23GF Score
Dare Bioscience Inc DARE
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Dare Bioscience (DARE) has a Tariff Resilience Score of 8 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Dare Bioscience ranks #18 out of 1374 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Dare Bioscience's Tariff Resilience Score too high?
Dare Bioscience's current Tariff Resilience Score is 8. The Biotechnology industry median Tariff Resilience Score is 4.00. Dare Bioscience's value of 8 is 100% above this industry median. Based on the distribution chart, Dare Bioscience ranks #18 out of 1374 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Dare Bioscience has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Dare Bioscience's Tariff Resilience Score compare to ATNM and NNVC?
According to the Biotechnology industry distribution chart, Dare Bioscience ranks #18 out of 1374 companies for Tariff Resilience Score. This places Dare Bioscience in the top 1% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Dare Bioscience's value of 8 is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dare Bioscience's current Tariff Resilience Score of 8 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dare Bioscience's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dare Bioscience stock overvalued right now?
Dare Bioscience (DARE) has a current Tariff Resilience Score of 8. The current Tariff Resilience Score is 8 and 100% above the Biotechnology industry median of 4.00. Dare Bioscience's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Dare Bioscience (DARE), the current Tariff Resilience Score is 8 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dare Bioscience Business Description

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
23GF Score

Get the complete analysis for DARE

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.09
Price